Cargando…
Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model
The yellow fever vaccine 17D (17D) is safe, and after a single immunizing dose, elicits long-lasting, perhaps lifelong protective immunity. One of the major challenges facing delivery of human vaccines in underdeveloped countries is the need for multiple injections to achieve full efficacy. To exami...
Autores principales: | Tao, Deng, Barba-Spaeth, Giovanna, Rai, Urvashi, Nussenzweig, Victor, Rice, Charles M., Nussenzweig, Ruth S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212788/ https://www.ncbi.nlm.nih.gov/pubmed/15657290 http://dx.doi.org/10.1084/jem.20041526 |
Ejemplares similares
-
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
por: Barba-Spaeth, Giovanna, et al.
Publicado: (2005) -
FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D
por: Scheck, Magdalena K., et al.
Publicado: (2022) -
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine
por: Wec, Anna Z., et al.
Publicado: (2020) -
Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees
por: Mateus, Jose, et al.
Publicado: (2020) -
Switching and emergence of CTL epitopes in HIV-1 infection
por: Han, Chungyong, et al.
Publicado: (2014)